Showing 6,049 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Hepatitis C treatment

Adverse CNS Effects of HCV Treatment Discourage Adherence

Editor's pick
Medscape (requires free registration)
21 November 2011
Treatment outcomes & life expectancy

Model shows excellent prognosis for UK gay men with HIV

News
21 November 2011
Ageing & HIV

Tailored Risk Profiles Guide Care of HIV Patients

Editor's pick
Medscape (requires free registration)
17 November 2011
Bad science & bogus treatments

Unfounded Claims Of HIV Cure Spikes Demand For Tokay Gecko In Southeast Asia

Editor's pick
Asian Scientist Magazine
16 November 2011
Pharmaceutical industry

Complete One-Pill, Once-Daily Prezista-Based HIV Regimen Enters Development

Editor's pick
AIDSMeds
16 November 2011
Pharmaceutical industry

Gilead and J&J expand HIV cocktail partnership

Editor's pick
CNBC
15 November 2011
New & experimental HIV treatments

Ritonavir dose of 50 mg could be sufficient to boost some protease inhibitors, trials needed

News
15 November 2011
Side effects

Product information for raltegravir updated to warn of Stevens Johnson syndrome and hypersensitivity reaction

News
10 November 2011
Hepatitis & HIV

Hepatitis C Surpasses HIV as Cause of Death in U.S.

Editor's pick
AIDSMeds
10 November 2011
Epidemiology

Copy of Hepatitis C Surpasses HIV as Cause of Death in U.S.

Editor's pick
Kaiser Daily Global Health Policy Report
10 November 2011
Resistance

Drug combinations pairing AZT and efavirenz have highest resistance risk

News
8 November 2011
Viral load

Low HIV viral load doesn't cause inflammation or increase the risk of death

News
8 November 2011
Bad science & bogus treatments

Journalist's Libel Suit Against AIDS Activist Dismissed

Editor's pick
New York Law Journal
7 November 2011
Adherence

New Technologies May Increase Adherence to HIV Drugs

Editor's pick
AIDSMeds.com
5 November 2011
Pharmaceutical industry

DFH Pharma Obtains Exclusive Rights to Second-Generation HIV Maturation Inhibitor Program

Editor's pick
DFH press release
1 November 2011
Health services & systems

Treatment Costs Higher When HIV Diagnosis Is Delayed

Editor's pick
Medscape (free registration required)
1 November 2011
Pharmaceutical industry

Over the Next Decade, the Dominance of Bristol-Myers Squibb Company 's Atripla in the HIV Drug Market Will Be Challenged by Gilead's Quad and Janssen's Complera

Editor's pick
Business Wire
28 October 2011
Pharmaceutical industry

Gilead posts higher profit, seeks Quad approval

Editor's pick
Reuters
27 October 2011
Treatment outcomes & life expectancy

Wide variations between US states in HIV mortality rates

News
27 October 2011
New & experimental HIV treatments

EACS: Does Maraviroc Intensification Promote Better CD4 Cell Recovery?

Editor's pick
HIVandhepatitis.com
27 October 2011
New & experimental HIV treatments

BMS to develop Reyataz fixed-dose pill with Gilead booster drug

Editor's pick
MarketWatch
26 October 2011
Improving HIV care

Standard definition of loss-to-follow-up for ART patients

Editor's pick
Eurekalert Inf Dis
25 October 2011
Young people

IDSA: Young Adult HIV Patients in Hospital More Often (CME/CE)

Editor's pick
MedPage Today HIV/AIDS
25 October 2011
Pharmaceutical industry

Innovative transdermal patch for delivery of HIV medicine

Editor's pick
Science Daily
25 October 2011